Healthcare -
Biotechnology - NASDAQ - US
$ 4.84
1.26 %
$ 288 M
Market Cap
-6.45
P/E
ALDX - STOCK-BASED COMPENSATION
Stock-based Compensation ALDX - Aldeyra Therapeutics, Inc.
5.75 M
LAST VALUE
-10.04%
2 YEAR CAGR
6.78%
5 YEAR CAGR
12.95%
10 YEAR CAGR